Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Ultra-low-dose Naloxone on Remifentanil-induced Postoperative Hyperalgesia - A Randomized Controlled Study

NCT02856087 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02856087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02856087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Ultra-low-dose Naloxone on Remifentanil-induced Postoperative Hyperalgesia - A Randomized Controlled Study
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2014
Completion date
April 30, 2015
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain